Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0311277 (
abdominal obesity
)
2,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To examine predictive factors for
abdominal obesity
or metabolic syndrome, we investigated the association of plasma fatty acid composition, estimated desaturase activity, and nutrient intakes, with
abdominal obesity
or metabolic syndrome in Japanese males. Clinical characteristics, the fatty acid composition of plasma cholesteryl esters, and energy and nutrient intakes were analyzed in 3 groups: metabolic syndrome (MS, n=24),
abdominal obesity
(OB, n=43), and control (n=27). The estimated desaturase activities were calculated by the ratio of 16:1n-7/16:0, 18:3n-6/18:2n-6, and 20:4n-6/20:3n-6 in plasma cholesteryl esters as surrogates of the measure of the delta 9, delta 6, delta 5 desaturase (D9-16D, D6D and
D5D
) activities, respectively. Plasma fatty acid composition did not differ significantly between the OB group and the control group. The MS group had higher levels of palmitoleic, oleic, and gamma-linolenic acids, but a lower level of linoleic acid than the control. Stronger D6D activity and weaker
D5D
activity were observed in the OB group. A higher level of D9-16D activity as well as a higher level of D6D activity and a lower level of
D5D
activity was observed in the MS group. A logistic regression analysis showed that the low
D5D
activity and high D9-16D activity were predictive of the development of
abdominal obesity
from controls (odds ratio=0.39, p<0.05) and metabolic syndrome from
abdominal obesity
(odds ratio=2.44, p<0.05), respectively. In the multiple linear regression analysis,
D5D
activity positively correlated with the intake of eicosapentaenoic acid (EPA). In conclusion, the estimated
D5D
activity was a predictive factor for
abdominal obesity
and the estimated D9-16D activity was a predictive factor for developing metabolic syndrome from
abdominal obesity
in Japanese male subjects. Dietary intake of EPA would play an important role in preventing
abdominal obesity
and the development of metabolic syndrome.
...
PMID:Plasma fatty acid composition, estimated desaturase activities, and intakes of energy and nutrient in Japanese men with abdominal obesity or metabolic syndrome. 1992 25